Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.
Patrice DufourLaurent VroonenCavalier EtienneCaroline Le GoffPublished in: Acta clinica Belgica (2022)
Considering the data in the literature and our clinical case, we suggest adding drospirenone and the ethinylestradiol/drospirenone association in the list of drugs interfering with aldosterone and renin level determination.